8-KLeadership Changes

DEXCOM INC 8-K Report, Executive Changes (Dec 10, 2020)

Filed December 10, 2020For Securities:DXCM

Summary

This 8-K filing from DexCom, Inc. (DXCM) on December 10, 2020, details the transition and consulting agreement for Richard B. Doubleday, Executive Vice President and Chief Commercial Officer, who is retiring effective December 31, 2020. The agreement ensures a smooth handover of responsibilities and leverages Mr. Doubleday's expertise during a transition period. Key aspects for investors include the structured phased retirement, the terms of his ongoing consulting services, accelerated vesting of certain stock units, and specific conditions related to severance and change-in-control events. This filing provides transparency regarding executive transitions and compensation arrangements.

Key Highlights

  • 1Richard B. Doubleday, EVP and Chief Commercial Officer, will retire effective December 31, 2020.
  • 2A Transition & Consulting Agreement has been established, effective December 10, 2020.
  • 3Mr. Doubleday will continue employment full-time until December 31, 2020, then part-time until March 31, 2021.
  • 4He will provide consulting services (approx. 30 hours/month) from April 1, 2021, to March 31, 2022, for a fee of $5,000 per month.
  • 5Certain Restricted Stock Units (RSUs) scheduled to vest between December 31, 2020, and March 31, 2022, will accelerate and vest on December 31, 2020, subject to specific waivers and releases.
  • 6Mr. Doubleday remains eligible for his 2020 bonus and is bound by a non-compete covenant during the consulting period.
  • 7Any unvested RSUs remaining after the accelerated vesting will be forfeited on April 1, 2021.

Frequently Asked Questions

This filing announces the retirement of Richard B. Doubleday, Executive Vice President and Chief Commercial Officer, and outlines the terms of his transition and consulting agreement with DexCom, Inc.

Mr. Doubleday will receive a reduced salary during his part-time employment until March 31, 2021, and a monthly consulting fee of $5,000 from April 1, 2021, to March 31, 2022. He will also receive his eligible 2020 bonus.

Specific Restricted Stock Units (RSUs) that were set to vest between December 31, 2020, and March 31, 2022, will accelerate and vest on December 31, 2020. Any remaining unvested RSUs after this acceleration will be forfeited on April 1, 2021.

Yes, Mr. Doubleday has agreed to a non-compete covenant during the consulting period (April 1, 2021, to March 31, 2022).